| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/2010 | CN101690767A Compound pesticide for fishing and preparation method and application thereof |
| 04/07/2010 | CN101690758A Compound datura flower asthma relieving powder for treating respiratory tract infection of pigs and preparation method thereof |
| 04/07/2010 | CN101690757A Method for preparing bezoar supernatant preparations |
| 04/07/2010 | CN101690750A External medicine for curing hyperosteogeny |
| 04/07/2010 | CN101690744A synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 04/07/2010 | CN101690740A Calculi dissolving agent for treating urologic calculi |
| 04/07/2010 | CN101690730A Method for quantum dot improvement and synchronous monitoring of antibacterial performance of ceftriaxone sodium |
| 04/07/2010 | CN101690728A Composition for treating osteoarthritis |
| 04/07/2010 | CN101690727A Medicament for treating arthritis and preparation method thereof |
| 04/07/2010 | CN101690726A Natural activating agent of peroxisome proliferator activated receptor-gamma |
| 04/07/2010 | CN101690725A Pharmaceutical composition for treating cardiovascular diseases and preparation method and use thereof |
| 04/07/2010 | CN101690724A Piperazine ferulate enteric preparation and preparation method thereof |
| 04/07/2010 | CN101690723A 琥珀酸舒马普坦复方制剂及其制备方法 Sumatriptan succinate compound and its preparation method |
| 04/07/2010 | CN101690722A Composition for slimming |
| 04/07/2010 | CN101690721A Synthetic bamboo and wood vinegar, and production method and applications thereof |
| 04/07/2010 | CN101690720A Carteolol orally disintegrating tablets and preparation method thereof |
| 04/07/2010 | CN101690719A Bisulfate clopidogrel solid preparation, particles and preparation method thereof |
| 04/07/2010 | CN101690718A Carteolol hydrochloride pellets, preparation method thereof and preparation thereof |
| 04/07/2010 | CN101690717A Valnemulin for livestock and saline premix and preparation method thereof |
| 04/07/2010 | CN101690714A Antimicrobial, antiprotozoal and antitumor allicin liposome and preparation method thereof |
| 04/07/2010 | CN101690713A Preparation method for carbostyril injection |
| 04/07/2010 | CN101690712A Sitafloxacin eye drop and preparation method thereof |
| 04/07/2010 | CN101690640A Drug curtain cloth preventing influenza A H1N1 and preparation method |
| 04/07/2010 | CN101273973B Pharmaceutical combination containing Mosapride citrate |
| 04/07/2010 | CN101224220B Compounds for strengthening organism immunity function and application thereof |
| 04/07/2010 | CN101199787B Medicament compound for treating skin disease |
| 04/07/2010 | CN101148483B Chitosan oligosaccharide-stearic acid grafting compound modified by folic acid, preparation method and application thereof |
| 04/07/2010 | CN101070354B Method for synchronous producing aloe polysaccharide powder and aloe active water using aloes |
| 04/07/2010 | CN101041641B Di-diamino dihydrogen triazine derivative and preparation method and usage thereof |
| 04/07/2010 | CN101032473B Sandwich type medical releasing film and preparing method thereof |
| 04/07/2010 | CN101023945B Use of non-periphery substituted phthalocyaniu metal complex |
| 04/07/2010 | CN101011442B Barrenwort extract fat emulsion composition and its preparing process |
| 04/07/2010 | CN101002791B Traditional Chinese medicine composition for treating cerebrovascular disease, and its preparing method |
| 04/06/2010 | USRE41209 Platinum complexes |
| 04/06/2010 | US7692059 Method for generating overexpression of alleles in genes of unknown function |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7692023 Candesartan cilexetil polymorphs |
| 04/06/2010 | US7692017 Such as 2-(Allyloxy)-4-(3-fluorophenyl)-6-methoxyquinoline-3-carbonitrile; for treating cardiac arrhthymias |
| 04/06/2010 | US7692014 Inhibitors of the HIV integrase enzyme |
| 04/06/2010 | US7692011 8-hydroxy and 8-mercapto quinazolinones |
| 04/06/2010 | US7692010 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia |
| 04/06/2010 | US7692009 Reference standard for characterization of rosuvastatin |
| 04/06/2010 | US7692008 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia |
| 04/06/2010 | US7692006 Phthalazinone derivatives |
| 04/06/2010 | US7691999 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA) |
| 04/06/2010 | US7691997 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 04/06/2010 | US7691986 High molecular weight, low methoxyl pectins, and their production and uses |
| 04/06/2010 | US7691907 Methods and composition based on discovery of metabolism of nitroglycerin |
| 04/06/2010 | US7691906 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 04/06/2010 | US7691905 Anticancer agents |
| 04/06/2010 | US7691904 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation as well as treating cancer, nervous system disorders and respiratory system disorders, |
| 04/06/2010 | US7691903 Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
| 04/06/2010 | US7691902 including cystic fibrosis transmembrane conductance regulator ("CFTR"); amido-phenyl derivatives; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis and lipid processing deficiencies, lysosomal storage disease |
| 04/06/2010 | US7691901 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
| 04/06/2010 | US7691900 nervous system disorders; by reducing activation of the microglia an/or astrocytes and/or by reducing reactive gliosis; |
| 04/06/2010 | US7691899 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices |
| 04/06/2010 | US7691898 Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia |
| 04/06/2010 | US7691897 Therapeutic agent |
| 04/06/2010 | US7691896 7,8-Dihydrosalinosporamide; inhibiting proteasome inhibiting proteasome; ischemic or reperfusion injury; cancer |
| 04/06/2010 | US7691895 3'-{N'-[1-(3,4-Dimethyl-phenyl)-2-oxo-1,2-dihydro-indol-3-ylidene]-hydrazino}-2'-hydroxy-biphenyl-3-carboxylic acid; receptor agonist; drug screening; thrombocytopenia |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691893 Chemical compounds |
| 04/06/2010 | US7691892 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 04/06/2010 | US7691891 Diphenylurea derivatives and their use as chloride channel blockers |
| 04/06/2010 | US7691890 Therapeutic treatment of virus infections; cell antigrowth agents; treating human herpes viruses |
| 04/06/2010 | US7691889 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide |
| 04/06/2010 | US7691888 Thiazolyl-dihydro-indazole |
| 04/06/2010 | US7691887 5-(1,1-Difluoroethyl)-3-(4-{4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}bicyclo[2.2.2]oct-1-yl)-1,2,4-oxadiazole; inhibitors of the Sonic Hedgehog pathway; prostate, non-small cell lung cancers, gastrointestinal cancer and bladder cancer |
| 04/06/2010 | US7691885 Pyridones useful as inhibitors of kinases |
| 04/06/2010 | US7691884 Heterocyclic sulfonamide inhibitors of β amyloid production |
| 04/06/2010 | US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 04/06/2010 | US7691882 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells |
| 04/06/2010 | US7691881 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity |
| 04/06/2010 | US7691880 liquid formulation contains at least one organic acid dissolved in a solvent; chemical stability, storage stability, shelf life; treating attention-deficit disorder in children |
| 04/06/2010 | US7691879 Isoquinoline potassium channel inhibitors |
| 04/06/2010 | US7691878 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 04/06/2010 | US7691877 Pharmaceuticals |
| 04/06/2010 | US7691876 1H-pyrrolo[2,3-c]pyridine-7-carboxylic acid (4-tert-butyl-benzyl)-[2-(4-fluoro-3-trifluoromethyl-phenyl)-ethyl]-amide; cardiovascular diseases such as atherosclerosis, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemi |
| 04/06/2010 | US7691875 Imidazopyridine compounds, processes for their preparation and therapeutic uses thereof |
| 04/06/2010 | US7691874 Treating symptoms of Parkinson's disease comprising administering an effective anti-Parkinsonism amount of 3-hydroxymorphinan (Norlevophanol); neuroprotectantsside effect reduction; cognition activators; Alzheimer's disease; drug abusepsychological disorders |
| 04/06/2010 | US7691873 Preparation of pharmaceutical formulations |
| 04/06/2010 | US7691872 Administering compound that binds human serum albumin (HSA) to increase free drug levels of the camptothecin compound during anti-topoisomerase I-based therapy in human |
| 04/06/2010 | US7691871 Multivitamin syrup for children or young adults |
| 04/06/2010 | US7691870 N-[4-(pyridine-4-yloxy)phenyl]-4-bromo-6-tefluoromethyl-1H-benzimidazole-2-carboxamide; for cancerous cell growth mediated by one or more raf-kinases |
| 04/06/2010 | US7691869 Pyrrolotriazolopyrimidine derivatives, pharmaceutical compositions containing them and methods of treating conditions and diseases mediated by the adenosine A2A receptor activity |
| 04/06/2010 | US7691868 N-{8-[2-chloro-5-(3-methylamino-prop-1-ynyl)-phenyl]-4,5-dihydro-thiazolo[4,5-h]quinazolin-2-yl}-acetamide; PI3-kinase modulators for the treatment of inflammatory or allergic diseases |
| 04/06/2010 | US7691867 Chemical compounds |
| 04/06/2010 | US7691866 Anticancer agents |
| 04/06/2010 | US7691865 4-(2-pyridin-2-yl-pyrazolo[1,5-a]pyridin-3-yl)-pyrimidin-2-ylamine; 4-[2-(6-methyl-pyridin-2-yl)-pyrazolo[1,5-a]pyrimidin-3-yl]-pyrimidin-2-ylamine; high affinity for Alk 5 and/or Alk 4 hence useful as antagonists thereof; fibrotic disorders |
| 04/06/2010 | US7691864 Anti-hypertensive composition and methods of treatment |
| 04/06/2010 | US7691863 Pyrazine-2-carboxamide derivatives as CB2 receptor modulators |
| 04/06/2010 | US7691862 Administering misoprostl and ciprofloxacin exceptional results in obtaining very significant regeneration of bone and cementum in periodontal pockets as determined by the very significant reduction in the depth of the periodontal pockets with or without surgical intervention |
| 04/06/2010 | US7691861 Indolymaleimide derivatives |
| 04/06/2010 | US7691860 Neuropeptide Y receptor antagonists; such as 2-(trans-4-tert-butylsulfonylaminocyclohexyl)-5-(trifluoromethyl)benzimidazole; bulimia, obesity, diabetes |
| 04/06/2010 | US7691859 prenyl transferase inhibitors; e.g. 8-butyl-7-(3-(imidazol-5-yl)-1-oxopropyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine; antitumor agents; cancer of breast, colon, pancreas, prostate, lung, ovarian, epidermal; hematopoietics; Ras-dependent tumor; |
| 04/06/2010 | US7691858 3-(2,4-Diaminopteridin-6-yl)phenol or 6-(1H-Indol-4-yl)pteridine-2,4-diamine;phosphoinositide 3-kinase; enzyme inhibitors; vasculostatic agents; antiinflammatory agents; antiarthric agents; transplant rejecction; autoimmune diseases; anticarcinogenic agents |
| 04/06/2010 | US7691857 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 04/06/2010 | US7691856 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands |
| 04/06/2010 | US7691855 {4-[3-(2,3-dimethyl-phenyl)-1H-pyrazol-4-yl]-pyrimidin-2-yl}-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine; antiproliferative agents; tumor |